Additionally, the unfavorable prognostic value of circ-PRMT1 overexpression was observed in OS analysis, which revealed that colorectal adenocarcinoma patients with circ-PRMT1 overexpression had significantly poorer OS (p < 0.001) (Figure 4B). This evidence concerns the gene PRMT1 and colorectal adenocarcinoma.